No Detail Found!

Cardioprotective effects of atorvastatin plus trimetazidine in percutaneous coronary intervention.

Author(s)
Xuefeng Lin Ministry of Education, Key Laboratory of Molecular Cardiology, Shannxi Province, No.277 Yanta West Road, Xi’an, P. R. China
Aiqun Ma Ministry of Education, Key Laboratory of Molecular Cardiology, Shannxi Province, No.277 Yanta West Road, Xi’an, P. R. China
Wei Zhang Ministry of Education, Key Laboratory of Molecular Cardiology, Shannxi Province, No.277 Yanta West Road, Xi’an, P. R. China
Qun Lu Department of Cardiovascular Medicine, First Affiliated Hospital of Baotou Medical College, No.41 Linyin Road, Baotou, 014010, P. R. China
Chaofeng Sun Department of Cardiovascular Medicine, First Affiliated Hospital of Baotou Medical College, No.41 Linyin Road, Baotou, 014010, P. R. China
Hongyan Tian Department of Cardiovascular Medicine, First Affiliated Hospital of Baotou Medical College, No.41 Linyin Road, Baotou, 014010, P. R. China
Xinjun Lei Department of Cardiovascular Medicine, First Affiliated Hospital of Baotou Medical College, No.41 Linyin Road, Baotou, 014010, P. R. China
Xiaojun Bai Department of Cardiovascular Medicine, First Affiliated Hospital of Baotou Medical College, Linyin Road, Baotou, 014010, P. R. China
Abstract
Objective: To explore the effects of preoperative administration of conventional doses of atorvastatin plus trimetazidine on the myocardial injury of patients during the perioperative period of percutaneous coronary intervention (PCI). Methodology: 475 cases of acute coronary syndrome patients before PCI were randomly divided into the control group (238 cases) and experimental group (237 cases).The control group was treated with conventional doses of atorvastatin calcium (20 mg each time, once a night), and the experimental group was treated with conventional doses of atorvastatin calcium plus trimetazidine hydrochloride (20 mg each time, tid) for 3 d. After PCI, preoperative and postoperative 24 h concentrations of serum creatine kinase MB isoenzyme (CK-MB), cardiac troponin I (cTnI) and high sensitivity C-reactive protein (hs-CRP) as well as activity of myeloperoxidase (MPO) were investigated. Left ventricular ejection fractions of the patients were then examined 4 weeks later. Results: Postoperative 24 h cTnI concentration and elevated MPO activity of the experimental group were significantly lower than those of the control group (P 0 05). Conclusion: The administration of conventional doses of atorvastatin plus trimetazidine three days before PCI is able to protect the perioperative patients from myocardial injury.
Publication Details
Page(s) 545-548
DOI DOI not available
Published Journal: Pakistan Journal of Medical Sciences, Volume: 29, Issue: 2, Year: 2013

Request the full text from PASTIC

0

Citations

0

Downloads

69

Views